Your browser doesn't support javascript.
loading
MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies.
Alcoceba, Miguel; García-Álvarez, María; Medina, Alejandro; Maldonado, Rebeca; González-Calle, Verónica; Chillón, María Carmen; Sarasquete, María Eugenia; González, Marcos; García-Sanz, Ramón; Jiménez, Cristina.
Affiliation
  • Alcoceba M; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • García-Álvarez M; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • Medina A; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • Maldonado R; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • González-Calle V; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • Chillón MC; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • Sarasquete ME; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • González M; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • García-Sanz R; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • Jiménez C; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
Int J Mol Sci ; 23(10)2022 May 16.
Article in En | MEDLINE | ID: mdl-35628381
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Waldenstrom Macroglobulinemia / Myeloid Differentiation Factor 88 / Mutation Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Humans Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Waldenstrom Macroglobulinemia / Myeloid Differentiation Factor 88 / Mutation Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Humans Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article Affiliation country: Country of publication: